PT - JOURNAL ARTICLE AU - Jean Claude, Makenga Bof AU - Paul, Mansiangi AU - Josué, Zanga AU - Félicien, Ilunga AU - Gilles Adjami, Ako Aime AU - Sounkalo, Sanfo Moussa AU - Bakajika, Didier AU - Yves, Coppieters TI - Ongoing transmission of human onchocerciasis in the district of Mont Ngafula 1 in Kinshasa after two decades of uninterrupted onchocerciasis annual mass campaigns using community directed treatment with Ivermectin strategy AID - 10.1101/2023.05.10.23289767 DP - 2023 Jan 01 TA - medRxiv PG - 2023.05.10.23289767 4099 - http://medrxiv.org/content/early/2023/05/11/2023.05.10.23289767.short 4100 - http://medrxiv.org/content/early/2023/05/11/2023.05.10.23289767.full AB - Background The district of Mont Ngafula I in Kinshasa, the capital city of the Democratic Republic of Congo (DRC) has been treating for onchocerciasis over the last two decades using community directed treatment with ivermectin strategy (CDTI). This study aimed to determine the transmission of onchocerciasis in blackflies after two decades of uninterrupted annual ivermectin mass campaigns using CDTI.Material Blackflies were collected at Kimwenza site in the district of Mont Ngafula 1 along Lukaya river from 1st August 2019 to 31st July 2020 using human landing catching techniques. Entomological indicators (biting rate, transmission potentials and infectivity rate) were calculated using O-150 Pool screening PCR technique.Results A total of 12,217 blackflies of Simulium squamosum species were collected during the study period. Two daily cycles of high biting were identified between 08:00 and 09:00 a.m. and 16:00 and 17:00. Low biting rates were observed between 11:00 a.m. and 13:00. The daily and annual biting rates were 774 and 22,380 bites/person (p = < 0.001). The infectivity rate was 0.09 % (95% CI: 0.04 - 0.17). The calculated annual transmission potential was 21).Conclusions The study showed an ongoing transmission of onchocerciasis in the study site despite two decades of uninterrupted ivermectin mass distribution campaigns using community directed treatment with ivermectin. There is an urgent need for alternative treatment strategies to accelerate the interruption of transmission of onchocerciasis.Author Summary Human onchocerciasis, also known as river blindness, is a neglected tropical disease targeted for elimination of transmission by the World Health Organization (WHO). Both epidemiological and entomological criteria are highly needed to confirm the interruption and elimination of transmission of onchocerciasis. Following rapid epidemiological mapping of Onchocerciasis conducted in 2001 in Kinshasa, the capital city of the Democratic Republic of Congo, the medical district of Mont Ngafula 1, Nsele and Binza Ozone were found to be mesoendemic for onchocerciasis and were treated using community directed treatment with ivermectin strategy (CDTI) for the last two decades. The aim of this study was to determine the impact of Ivermectin community mass distribution on onchocerciasis transmission in blackflies in the health district of Mont Ngafula 1 after two decades of preventive chemotherapy. A total of 12,217 blackflies were collected from 1st August 2019 to 31st July 2020 using human landing catching technique. Biting rate and annual potential transmission were calculated and infectivity rate determined using the O-150 PCR technique. The findings confirmed an ongoing transmission of onchocerciasis in blackflies in the health district of Mont Ngafula 1 despite two decades on uninterrupted Ivermectin mass administration. There is an urgent call for alternative treatment strategies to accelerate the interruption of transmission of onchocerciasis in the study site.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Republique Democratique du Congo, Universite de Kinshasa, Ecole de Sante Publique, Comite d'Ethique, numero d'approbation ESP/CE/139/2019I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptABRannual biting rateAPOCAfrican Programme for Onchocerciasis ControlATPannual transmission potentialCDTICommunity Directed Treatment with IvermectinDBRdaily biting rateDRCDemocratic Republic of CongoDTTdichlorodiphenyltrichloroethaneESPENExpanded Special Project for Elimination of Neglected Tropical DiseasesESPKEcole de Santé Publique de KinshasaHLCHuman Landing CatchISTMInstitut Supérieur des Techniques MédicalesMBRmonthly biting rateMDAmass drug administrationMTPmonthly transmission potentialNPOCNational Program for Onchocerciasis ControlNSNon-significantNTDsneglected tropical diseasesPNLMTN-CPNational Programme for Neglected Tropical Diseases ControlREMORapid Epidemiological Mapping of OnchocerciasisSDStandard deviationULBUniversité Libre de BruxellesUNIKINUniversité de KinshasaWHOWorld Health Organization